BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 30307748)

  • 1. Commentary: Campylobacter and Hemolytic Uremic Syndrome.
    Smith JL; Gunther NW
    Foodborne Pathog Dis; 2019 Feb; 16(2):90-93. PubMed ID: 30307748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-infection in children with bloody diarrhea caused by Shiga toxin-producing Escherichia coli: data of the North Italian HUS Network.
    Ardissino G; Possenti I; Salardi S; Tel F; Colombo E; Testa S; Daprai L; Picicco D; Colombo RM; Torresani E
    J Pediatr Gastroenterol Nutr; 2014 Aug; 59(2):218-20. PubMed ID: 24824362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental In Vivo Models of Bacterial Shiga Toxin-Associated Hemolytic Uremic Syndrome.
    Jeong YJ; Park SK; Yoon SJ; Park YJ; Lee MS
    J Microbiol Biotechnol; 2018 Sep; 28(9):1413-1425. PubMed ID: 29926707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemolytic uremic syndrome due to Shiga toxin-producing Escherichia coli infection.
    Bruyand M; Mariani-Kurkdjian P; Gouali M; de Valk H; King LA; Le Hello S; Bonacorsi S; Loirat C
    Med Mal Infect; 2018 May; 48(3):167-174. PubMed ID: 29054297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemolytic Uremic Syndrome Associated With Non-Shigatoxin-producing Infectious Agents: Expanding the Shigatoxin Theory.
    Keenswijk W; Degraeuwe E; Dhont E; Raes A; Vande Walle J
    J Pediatr Hematol Oncol; 2019 Apr; 41(3):e179-e181. PubMed ID: 29683956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemolytic-Uremic Syndrome and Escherichia coli O121 at a Lake in Connecticut, 1999.
    McCarthy TA; Barrett NL; Hadler JL; Salsbury B; Howard RT; Dingman DW; Brinkman CD; Bibb WF; Cartter ML
    Pediatrics; 2001 Oct; 108(4):E59. PubMed ID: 11581467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extrarenal manifestations of the hemolytic uremic syndrome associated with Shiga toxin-producing Escherichia coli (STEC HUS).
    Khalid M; Andreoli S
    Pediatr Nephrol; 2019 Dec; 34(12):2495-2507. PubMed ID: 30382336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of complement monoclonal antibody eculizumab in Shiga toxin producing Escherichia coli associated hemolytic uremic syndrome: A review of current evidence.
    Mahat U; Matar RB; Rotz SJ
    Pediatr Blood Cancer; 2019 Nov; 66(11):e27913. PubMed ID: 31286658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New insights into Shiga toxin-mediated endothelial dysfunction in hemolytic uremic syndrome.
    Petruzziello-Pellegrini TN; Moslemi-Naeini M; Marsden PA
    Virulence; 2013 Aug; 4(6):556-63. PubMed ID: 23955166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An epidemiologic surveillance of Shiga-like toxin-producing Escherichia coli infection in Argentinean children: risk factors and serum Shiga-like toxin 2 values.
    López EL; Contrini MM; Glatstein E; Ayala SG; Santoro R; Ezcurra G; Teplitz E; Matsumoto Y; Sato H; Sakai K; Katsuura Y; Hoshide S; Morita T; Harning R; Brookman S
    Pediatr Infect Dis J; 2012 Jan; 31(1):20-4. PubMed ID: 21829137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Shiga toxin genotype rather than the amount of Shiga toxin or the cytotoxicity of Shiga toxin in vitro correlates with the appearance of the hemolytic uremic syndrome.
    Orth D; Grif K; Khan AB; Naim A; Dierich MP; Würzner R
    Diagn Microbiol Infect Dis; 2007 Nov; 59(3):235-42. PubMed ID: 17931818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenic role of inflammatory response during Shiga toxin-associated hemolytic uremic syndrome (HUS).
    Exeni RA; Fernandez-Brando RJ; Santiago AP; Fiorentino GA; Exeni AM; Ramos MV; Palermo MS
    Pediatr Nephrol; 2018 Nov; 33(11):2057-2071. PubMed ID: 29372302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clostridium septicum infection complicating Hemolytic-Uremic Syndrome: a case report and review of the literature.
    Cirillo L; Noris A; Odone L; Giordano F; Becherucci F
    J Nephrol; 2024 Jan; 37(1):181-186. PubMed ID: 37314614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virulence factors of Shiga toxin-producing Escherichia coli and the risk of developing haemolytic uraemic syndrome in Norway, 1992-2013.
    Naseer U; Løbersli I; Hindrum M; Bruvik T; Brandal LT
    Eur J Clin Microbiol Infect Dis; 2017 Sep; 36(9):1613-1620. PubMed ID: 28391537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human monocytes stimulated by Shiga toxin 1a via globotriaosylceramide release proinflammatory molecules associated with hemolytic uremic syndrome.
    Brigotti M; Carnicelli D; Arfilli V; Porcellini E; Galassi E; Valerii MC; Spisni E
    Int J Med Microbiol; 2018 Oct; 308(7):940-946. PubMed ID: 29983334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low risk of hemolytic uremic syndrome after early effective antimicrobial therapy for Shigella dysenteriae type 1 infection in Bangladesh.
    Bennish ML; Khan WA; Begum M; Bridges EA; Ahmed S; Saha D; Salam MA; Acheson D; Ryan ET
    Clin Infect Dis; 2006 Feb; 42(3):356-62. PubMed ID: 16392080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Particulate Shiga Toxin 2 in Blood is Associated to the Development of Hemolytic Uremic Syndrome in Children.
    Brigotti M; He X; Carnicelli D; Arfilli V; Porcellini E; Galassi E; Tazzari PL; Ricci F; Patfield SA; Testa S; Paglialonga F; Picicco D; Caprioli A; Scavia G; Morabito S; Ardissino G
    Thromb Haemost; 2020 Jan; 120(1):107-120. PubMed ID: 31858520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemolytic uremic syndrome in children.
    Talarico V; Aloe M; Monzani A; Miniero R; Bona G
    Minerva Pediatr; 2016 Dec; 68(6):441-455. PubMed ID: 27768015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical reduction of plasma ADAMTS13 activity by a non-IgG-type inhibitor in a patient with hemolytic uremic syndrome caused by Shiga toxin-producing Escherichia coli.
    Nakayama S; Hirashio S; Yorishima H; Doi T; Yoshida Y; Matsumoto M; Masaki T
    CEN Case Rep; 2019 Nov; 8(4):266-270. PubMed ID: 31177384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infections in pediatric postdiarrheal hemolytic uremic syndrome: factors associated with identifying shiga toxin-producing Escherichia coli.
    Mody RK; Luna-Gierke RE; Jones TF; Comstock N; Hurd S; Scheftel J; Lathrop S; Smith G; Palmer A; Strockbine N; Talkington D; Mahon BE; Hoekstra RM; Griffin PM
    Arch Pediatr Adolesc Med; 2012 Oct; 166(10):902-9. PubMed ID: 22869280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.